| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |